Treatment-Related Variables | Category | Overall Survival | P |
---|---|---|---|
Sex | Male | 28.6% | 0.876 |
Female | 25.5% | ||
Age (years) | < 51 | 30.6% | 0.243 |
> 51 | 23.5% | ||
Region of recurrence | Pelvic | 20.8% | 0.588 |
Retroperitoneal | 33.4% | ||
Local failure | Yes | 44.2% | 0.006 |
No | 0% | ||
Distant failure | Yes | 10.3% | 0.042 |
No | 52.9% | ||
Resection grade | R0 | 35.8% | 0.12 |
R1 | 0% | ||
EBRT (first-line treatment) | Yes | 17.9% | 0.109 |
No | 30.4% | ||
Association with adjuvant EBRT | Yes | 21.4% | 0.687 |
No | 34.7% | ||
Association with neoadjuvant chemotherapy | Yes | 0% | 0.157 |
No | 28.6% | ||
Association with adjuvant chemotherapy | Yes | 38.1% | 0.347 |
No | 23.1% | ||
Histology | Sarcoma | 6,7% | 0.005 |
Epithelial | 40% | ||
Group of tumors | Colorectal Tumors | 43% | 0.09 |
Retroperitoneal Sarcomas | 7% | 0.005 | |
Gynecological Tumors | 30% | 0.43 |